CDTX vs PAYC · rev $1.3M vs P/E 33, rev $1.88B
Cidara Therapeutics Inc (CDTX) versus Paycom Soft (PAYC) — a side-by-side from cached financials, not a winner call.
Cidara Therapeutics Inc (CDTX) is a biotechnology company listed on US.
Paycom Soft (PAYC) is a software - application company listed on US.
Latest reported CDTX revenue for 2024-12-31 was $1.3M. Net income was -$169.8M. Revenue was down 94.5% from 2023-12-31 to 2024-12-31. CDTX currently screens at market cap $6.96B.
Latest reported PAYC revenue for 2024-12-31 was $1.88B. Net income was $502.0M. Revenue was up 11.2% from 2023-12-31 to 2024-12-31. PAYC currently screens at market cap $13.06B and trailing P/E 33.1.
CDTX currently screens at market cap $6.96B. PAYC currently screens at market cap $13.06B and trailing P/E 33.1.
Not investment advice. Open the CDTX and PAYC stock pages for the full models.
Not investment advice.